Similar articles

• The clinical use of triethylene melamine.

  KRAVITZ SC, DIAMOND HD, CRAVER LF. KRAVITZ SC, et al. Blood. 1952 Jul;7(7):729-42. Blood. 1952. PMID: 14934758 No abstract available.
• [SURVIVAL TIME AND ABILITY TO WORK IN HEMOBLASTOSES TREATED BY CHEMOTHERAPY].

  PRAETORIUS E. PRAETORIUS E. Dtsch Arch Klin Med. 1963 Dec 2;209:192-218. Dtsch Arch Klin Med. 1963. PMID: 14126764 German. No abstract available.
• [Results of triethylene melanine therapy of Hodgkin's disease and of chronic myeloid leukemia; preliminary communication].

  GARCIGA CE. GARCIGA CE. Arch Cuba Cancerol. 1953 Jan-Jun;12(1-6):39-46. Arch Cuba Cancerol. 1953. PMID: 13066241 Undetermined Language. No abstract available.
• [THE THERAPY OF LEUKEMIAS].

  CARDINALI G. CARDINALI G. Rass Clin Ter. 1964;63:252-85. Rass Clin Ter. 1964. PMID: 14204662 Review. Italian. No abstract available.
• CORTICOSTEROIDS IN THE MANAGEMENT OF HODGKIN'S DISEASE AND THE LEUKEMIAS. V. CLINICAL REPORTS, 1959-62.

  SAMPEY JR. SAMPEY JR. Am J Pharm Sci Support Public Health. 1963 Jul;135:257-68. Am J Pharm Sci Support Public Health. 1963. PMID: 14050698 Review. No abstract available.